September 19, 2022 Eric I. Richman c/o Gain Therapeutics, Inc. Suite 220 Bethesda, MD 20814 Re: Transition Agreement Dear Eric:Consulting Agreement • September 20th, 2022 • Gain Therapeutics, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledSeptember 20th, 2022 Company Industry JurisdictionThis letter sets forth the substance of the Transition Agreement (the “Agreement”) which Gain Therapeutics Inc. (the “Company”) is offering to you to aid in your employment transition.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2022 • Gain Therapeutics, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledSeptember 20th, 2022 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Agreement”) is effective as of September 20, 2022 (“Effective Date”), by and between Gain Therapeutics, Inc. (“Company”) and Matthias Alder (“Executive”). This Agreement amends, restates, and supersedes in its entirety the Employment Agreement between the Company and Executive entered into effective October 15, 2021 (the “Prior Agreement”).